Evaluation of an individualized strategy of cavotricuspid isthmus ablation as an adjunct to atrial fibrillation ablation

J Cardiovasc Electrophysiol. 2007 Sep;18(9):926-30. doi: 10.1111/j.1540-8167.2007.00896.x. Epub 2007 Jul 26.

Abstract

Objectives: To evaluate supplementary cavotricuspid isthmus (CTI) ablation as an adjunct to atrial fibrillation (AF) ablation in selected patients.

Background: It is unclear whether routine CTI ablation is beneficial in all patients undergoing AF ablation.

Methods and results: In patients undergoing AF ablation, additional CTI block was created only for those with typical atrial flutter (Afl) before or during the ablation. Out of 188 consecutive patients (108 male, 56 +/- 9 years), 75 underwent CTI ablation (Group CTI+) and left atrial (LA) ablation (circular mapping-guided extensive pulmonary vein isolation in all and linear LA ablation when required), while 113 underwent LA ablation alone (Group CTI-). Group CTI+ patients had smaller LA and less frequently persistent/permanent AF and linear LA ablation. Over a follow-up of 30 +/- 10 months, complications (4% vs 5%, P = NS), typical Afl occurrence (1.3% and 2.6%, P = NS) and AF recurrence (25% and 28%, P = NS) were similar. Atypical Afl was more common in Group CTI- (4 vs 14%, P = 0.026). Eighty-two percent and 79% of patients in Groups CTI+ and CTI-, respectively, remained arrhythmia free in stable sinus rhythm without antiarrhythmic drug treatment (P = NS).

Conclusions: Avoiding supplementary CTI ablation in AF ablation patients without evidence of typical flutter does not result in a higher incidence of typical Afl. Despite more persistent/permanent AF and larger LA in patients without evidence of typical flutter, a strategy of selective supplementary ablation resulted in similar and low AF recurrence rates in the group without CTI ablation compared with the group with CTI ablation.

Publication types

  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Atrial Fibrillation / surgery*
  • Catheter Ablation / methods*
  • Combined Modality Therapy / methods
  • Female
  • Heart Atria / surgery*
  • Heart Conduction System / surgery*
  • Humans
  • Male
  • Middle Aged
  • Secondary Prevention
  • Treatment Outcome
  • Tricuspid Valve / surgery*